Michael Schöll (Former)
1 – 10 of 68
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Clinical translation of fluid, imaging, and digital biomarkers for Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
Cognitive Trajectories from Preclinical Alzheimer's Disease to Dementia
(2026) In Advanced Science
- Contribution to journal › Article
-
Mark
Self-reported sleep quality and longitudinal amyloid burden in clinically unimpaired adults from the AMYPAD PNHS study
- Contribution to journal › Article
-
Mark
Emerging directions in tauopathy research
- Contribution to journal › Scientific review
-
Mark
Alzheimer's disease Stage 1 and 2 : Biology, diagnostics, and treatment
- Contribution to journal › Scientific review
-
Mark
Fluid biomarkers for neurodegenerative diseases : a comprehensive update
- Contribution to journal › Scientific review
-
Mark
Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease
- Contribution to journal › Article
- 2025
-
Mark
Cutting through the noise : A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use
- Contribution to journal › Scientific review
-
Mark
Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Amyloid PET predicts atrophy in older adults without dementia : Results from the AMYPAD Prognostic & Natural History study
- Contribution to journal › Article
